Maertens
JA
et al. Isavuconazole versus
voriconazole for primary treatment of invasive mould disease caused by
Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016 Feb 20;387(10020):760–9.
[PubMed: 26684607]